MedPath
FDA Approval

Ultramicrosize Griseofulvin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
August 9, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Griseofulvin(250 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Chartwell Pharmaceuticals Congers, LLC.

Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc

Chartwell Pharmaceuticals Congers, LLC.

118673447

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ultramicrosize Griseofulvin

Product Details

NDC Product Code
23155-864
Application Number
ANDA061996
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 9, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: 32HRV3E3D5Class: ACTIBQuantity: 250 mg in 1 1

Ultramicrosize Griseofulvin

Product Details

NDC Product Code
23155-863
Application Number
ANDA061996
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 9, 2023
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: 32HRV3E3D5Class: ACTIBQuantity: 125 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath